SCHEDULE 13G: AWM Investment Company Discloses 7.1% Stake in SANUWAVE Health, Inc.

Sentiment:

Beneficial Ownership Report


AWM Investment Company, Inc. has filed a Schedule 13G, reporting beneficial ownership of 7.1% of SANUWAVE Health, Inc.'s Common Stock as of December 31, 2024.

Summary

  • AWM Investment Company, Inc., a Delaware corporation and investment adviser, has filed a Schedule 13G with the U.S. Securities and Exchange Commission.
  • The filing indicates that AWM Investment Company, Inc. beneficially owns an aggregate of 606,061 shares of SANUWAVE Health, Inc.'s Common Stock.
  • This ownership stake represents 7.1% of the total outstanding shares of the class of securities.
  • AWM holds sole voting and dispositive power over these shares, which are held across four funds it advises: Special Situations Cayman Fund, L.P. (91,948 shares), Special Situations Fund III QP, L.P. (330,835 shares), Special Situations Private Equity Fund, L.P. (109,091 shares), and Special Situations Life Sciences Fund, L.P. (74,187 shares).
  • The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of SANUWAVE Health, Inc.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of beneficial ownership and does not contain qualitative statements that would indicate a positive or negative sentiment regarding the issuer's performance or outlook.

Future Outlook

NA

Industry Context

This filing indicates a significant institutional investment in SANUWAVE Health, Inc. by AWM Investment Company, Inc., an investment adviser specializing in equity and equity-related securities. While the filing itself does not provide broader industry analysis, a substantial stake by an investment firm can signal confidence in the company's prospects within its sector.

Stakeholder Impact

  • Shareholders: The disclosure of a significant institutional stake by AWM Investment Company, Inc. may be perceived positively, potentially indicating increased institutional interest and confidence in SANUWAVE Health, Inc.

Key Dates

DateDescription
12/31/2024Date of event which requires filing of this statement, reflecting the beneficial ownership percentage.
02/13/2025Date of filing of this Schedule 13G statement with the SEC.

Keywords

SANUWAVE Health, AWM Investment Company, Schedule 13G, beneficial ownership, common stock, investment adviser, SEC filing, institutional ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.